Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

BTL Emsella Chair Versus Sham for the Treatment of Stress Urinary Incontinence

NCT: NCT04133675 · RECRUITING

NCT IDNCT04133675
StatusRECRUITING
Start Date2019-12-18
Completion2028-12
SponsorCorewell Health East (OTHER)
First posted
Last updated

Brief Summary

Stress urinary incontinence (SUI) is a condition that affects both men and women. SUI is the involuntary leakage of urine caused by an increase in intra-abdominal pressure from activities such as exercise, coughing, laughing, or sneezing. It can significantly affect quality of life as patients avoid activities or behaviors that cause leakage. This clinical trial will compare the efficacy of the Emsella chair to sham and determine if electromagnetic technology is effective in the treatment of SUI.

Frequently Asked Questions

What is BTL Emsella Chair Versus Sham for the Treatment of Stress Urinary Incontinence?

BTL Emsella Chair Versus Sham for the Treatment of Stress Urinary Incontinence is a clinical trial registered under NCT04133675. Current status: RECRUITING.

What is the status of NCT04133675?

The current status of NCT04133675 (BTL Emsella Chair Versus Sham for the Treatment of Stress Urinary Incontinence) is: RECRUITING.

When did BTL Emsella Chair Versus Sham for the Treatment of Stress Urinary Incontinence start?

BTL Emsella Chair Versus Sham for the Treatment of Stress Urinary Incontinence started on 2019-12-18.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.